期刊文献+

沙眼衣原体CT058蛋白在感染细胞中的定位分析

Intracellular localization of the hypothetical protein CT058 in the Chlamydia trachomatis-infected cells
原文传递
导出
摘要 分析沙眼衣原体CT058蛋白在感染细胞中的定位。克隆表达CT058蛋白;纯化的CT058融合蛋白免疫小鼠制备多克隆抗体;间接免疫荧光法对CT058蛋白在沙眼衣原体感染细胞中的定位进行分析;Western blot检测CT058蛋白在原体和网状体中的表达情况。间接免疫荧光染色实验显示CT058蛋白位于包涵体内;鼠抗GST-CT058抗体与GST-CT058融合蛋白吸附后特异性染色消失,而与GST-CT232融合蛋白吸附后仍然可见GST-CT058抗体的包涵体染色特征;Western blot证实CT058蛋白在纯化的原体和网状体上均有表达。CT058蛋白定位于沙眼衣原体感染细胞的包涵体内。 To tract the intracellular localization of the hypothetical protein CT058 in the Chlamydia trachomatis-infected cells. The gene ct058 was expressed as GST-CT058 fusion protein in E. coli and its antibody was prepared by immunizing mouse with the fusion protein. Then, the anti-GST-CT058 antibody was used to localize the endogenous protein in cells infected by C. trachomatis serovar L2 using indirect immunofluorescence assay (IFA). Western blot was carried out to detect whether CT058 presents in the purified elementary body (EB) or reticulate body (RB). The anti-GST-CT058 antibody detected an inclusion-inside signal in an IFA. The intra-inclusion signal could be removed by pre-absorption of the antibody with the GST-CT058 fusion protein but not control GST-CT232. Furthermore, the mouse anti-CT058 antibody recognized the endogenous CT058 protein from purified EBs and RBs in a Western blot assay. The results of the current study support the general consensus that the hypothetical protein CT058 was localized within the inclusion body of the C. trachomatis-infected cells.
出处 《微生物学通报》 CAS CSCD 北大核心 2011年第12期1863-1868,共6页 Microbiology China
基金 湖南省高校"病原体致病机制与防治"科技创新团队专项(湘教通[2010]212号)
关键词 沙眼衣原体 CT058 亚细胞定位 Chlamydia trachomatis, CT058, Subcellular localization
  • 相关文献

参考文献3

二级参考文献48

  • 1O'Connell CM, Ingalls RR, Andrews CW, et al. Plasmid-deficient Chlamydia muridarum fail to induce immune pathology and protect against oviduct disease [J]. J |mmunol, 2007,179 (64):4027-4034.
  • 2Pickett MA, Everson JS, Pead PJ, et al. The plasmids of Chlamydia trachomatis and Chlamydophila pneumoniae (N16): accurate determination of copy number and the paradoxical effect of plasmid-curing agents [J]. Microbiology, 2005, 151: 893-903.
  • 3Dong F, Zhong Y, Arulanandam B, et al. Production of a proteolytically active protein, chlamydial protease/proteasome-like activity factor, by five different Chlamydia species [J]. Infect Immun, 2005, 73:1868-1872.
  • 4Sharma J, Dong F, Pirbhai M, et al. Inhibition of proteolytic activity of a chlamydial proteasome/protease-like activity factor by antibodies from humans infected with Chlamydia trachomatis[J]. Infect Immun, 2005, 73: 4414-4419.
  • 5Xiao Y, Zhong Y, Su H, et al. NF-kappa B activation is not required for Chlamydia trachomafis inhibition of host epithe- lial cell apoptosis[J]. J Immunol, 2005, 174:1701-1708.
  • 6Smith JS, Munoz N, Herrero R, et al. Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Phihppines [J]. J Infect Dis, 2002, 185(3) : 324-331.
  • 7Coker PR, Smith KL Fellows PF, et al. Bacillus anthracis virulence in guinea pigs vaccinated with anthrax vaccine adsorbed is linked to plasmid quantities and clonality[J]. J Chn Microbiol, 2003, 41:1212-1218.
  • 8Sharma J, Zhong Y, Dong F, et al. Profiling of human antibody responses to Chlamydia trachomatis urogenital tract infection using microplates arrayed with 156 chlamydial fusion proteins[J]. Infect Immun, 2006, 74(3):1490-1499.
  • 9Sharma J, Bosnic AM, Piper JM, et al. Human antibody responses to a Chlamydia-secreted protease factor [J]. Infect Immun, 2004, 72( 12):7164-7171.
  • 10Chaganty BK, Murthy AK, Evani S J, et al. Heat denatured enzymatically inactive recombinant chlamydial protease-like activity factor induces robust protective immunity against genital chlamydial challenge [J]. Vaccine, 2010, 28 (11)2323-2329.

共引文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部